Jiuden Pharmaceutical: JIJ02 gel is expected to complete Phase I clinical trials in the first half of next year.

Jiudian Pharmaceutical stated during an institutional research visit on September 12 that, based on the current research and development progress, JIJ02 gel is expected to complete Phase I clinical trials in the first half of next year and initiate Phase II clinical trials.